Lam Research Corporation $LRCX Stock Position Increased by Swedbank AB

Swedbank AB increased its position in Lam Research Corporation (NASDAQ:LRCXFree Report) by 3.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,255,637 shares of the semiconductor company’s stock after buying an additional 112,923 shares during the quarter. Swedbank AB’s holdings in Lam Research were worth $435,930,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. IMG Wealth Management Inc. acquired a new stake in Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research in the 2nd quarter worth approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $29,000. Delos Wealth Advisors LLC acquired a new stake in Lam Research during the second quarter valued at approximately $30,000. Finally, REAP Financial Group LLC acquired a new stake in Lam Research during the second quarter valued at approximately $31,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 102,608 shares of company stock worth $14,916,496 in the last ninety days. Company insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on LRCX shares. Cantor Fitzgerald restated an “overweight” rating and issued a $210.00 price target on shares of Lam Research in a research report on Tuesday, December 16th. JPMorgan Chase & Co. raised their price objective on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, October 23rd. BNP Paribas Exane upped their target price on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Zacks Research lowered Lam Research from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Finally, Wells Fargo & Company boosted their price objective on Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $161.21.

Read Our Latest Stock Analysis on LRCX

Lam Research Price Performance

NASDAQ LRCX opened at $175.16 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The firm has a market capitalization of $220.01 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 2.02 and a beta of 1.77. The company has a 50 day simple moving average of $156.31 and a 200-day simple moving average of $124.61. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $177.29.

Lam Research (NASDAQ:LRCXGet Free Report) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the prior year, the business earned $0.86 EPS. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.